SARS-CoV-2 pneumonia and Eisenmenger's Syndrome : doubling the challenge

Eisenmenger's syndrome (ES) is the most severe phenotype of pulmonary arterial hypertension (PAH) secondary to congenital heart disease. In these cases, a significant systemic-to-pulmonary (left-to-right) shunting triggers the development of pulmonary vascular disease (PVD) and pulmonary hypertension. In cases of acute hypoxemic respiratory failure in patients with ES, high flow nasal cannula (HFNC) oxygen therapy should be considered as a first-line approach in order to avoid pulmonary complications and right ventricular overload related to positive pressure ventilation. Here, we report a case of HFNC use in a patient with COVID-19 infection and ES.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - year:2023

Enthalten in:

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace - (2023) vom: 06. Nov.

Sprache:

Englisch

Beteiligte Personen:

Pierucci, Paola [VerfasserIn]
De Michele, Lucrezia [VerfasserIn]
De Candia, Maria Luisa [VerfasserIn]
Barratta, Federica [VerfasserIn]
Gregoretti, Cesare [VerfasserIn]
Carpagnano, Giovanna Elisiana [VerfasserIn]
Misseri, Giovanni [VerfasserIn]

Links:

Volltext

Themen:

Journal Article

Anmerkungen:

Date Revised 06.11.2023

published: Print-Electronic

Citation Status Publisher

doi:

10.4081/monaldi.2023.2741

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM364224886